Top Industry Leaders in the Europe Diabetes Pen Market
Latest Europe, the Middle East and Africa Diabetes Pen Companies Updates:
Novo Nordisk (Denmark):Launched its next-generation insulin pen, FlexTouch®, in Europe in June 2023. FlexTouch features a pre-filled insulin cartridge, easy dose adjustment mechanism, and a sleek design.Received FDA approval for its Ozempic® pen for treating type 2 diabetes in July 2023. Ozempic is a GLP-1 receptor agonist known for its long-lasting blood sugar control and weight management benefits.
Sanofi (France):Partnered with Novo Nordisk, Eli Lilly, and Merck KGaA to launch the world's first cross-industry initiative for recycling insulin pens in Denmark in April 2023. This initiative aims to address the environmental concerns associated with plastic waste from disposable pens.Developed its SoloStar® pen with an eco-design focus, reducing plastic usage and incorporating recycled materials. Sanofi has also launched take-back programs for SoloStar® pens in several European countries.
Eli Lilly (US):Received European Commission approval for its Basaglar® K12 insulin pen for treating type 2 diabetes in May 2023. Basaglar® K12 offers extended-release basal insulin and requires fewer injections compared to other long-acting insulins.Invested in digital health solutions like the Trulicity® My Dose app to help patients manage their diabetes with their insulin pens.
Owen Mumford (UK):Introduced its Echo® pen injector with voice guidance in Europe in August 2023. Echo® provides audio instructions for each step of the injection process, improving accessibility for visually impaired users.Focused on developing smart pens with integrated Bluetooth connectivity to track injection data and improve medication adherence.
List of Europe, the Middle East and Africa Diabetes Pen Key companies in the market:
- Becton, Dickinson And Company
- Novo Nordisk A/S
- Ypsomed Holding Ag
- Owen Mumford. Ltd
- Sanofi
- Eli Lilly
- Merck Animal Health